NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
55,473,383
Share change
+2,895,070
Total reported value
$126,469,266
Put/Call ratio
232567%
Price per share
$2.28
Number of holders
80
Value change
+$7,073,752
Number of buys
34
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q3 2015

As of 30 Sep 2015, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 80 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,473,383 shares. The largest 10 holders included Platinum Management (NY) LLC, Commerzbank Aktiengesellschaft /FI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, BlackRock Fund Advisors, UBS Group AG, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 80 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.